Go to the Table of Contents

Search tables for keyword
Please note: A selected table may take a few minutes to load.

Results from the 2018 National Survey on Drug Use and Health:
Detailed Tables

190522
Table 11.1A – Settings Where Mental Health Services Were Received in Past Year among Persons Aged 12 to 17: Numbers in Thousands, 2002-2018
Setting Where Mental Health Service
Was Received
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
SPECIALTY MENTAL HEALTH SERVICE1 2,898a 3,065a 3,348a 3,362a 3,255a 3,104a 3,129a 2,925a 2,920a 3,101a 3,118a 3,341a 3,369a 3,253a 3,598a 3,646a 3,901
Outpatient 2,662a 2,795a 3,015a 3,048a 2,931a 2,787a 2,837a 2,650a 2,635a 2,842a 2,846a 3,064a 3,110a 2,958a 3,239a 3,328 3,547
Private Therapist, Psychologist,
   Psychiatrist, Social Worker, or
   Counselor
2,254a 2,347a 2,523a 2,573a 2,416a 2,365a 2,408a 2,296a 2,265a 2,409a 2,427a 2,572a 2,698a 2,532a 2,819a 2,908 3,080
Mental Health Clinic or Center 611a 635a 716a 657a 587a 583a 567a 537a 547a 547a 610a 731a 760a 792a 929 995 977
Partial Day Hospital or Day Treatment
   Program
440 425 439 449 471 416 374a 340a 362a 393a 431 477 467 455 489 505 484
In-Home Therapist, Counselor, or Family
   Preservation Worker
693a 656a 762a 731a 719a 707a 716a 657a 674a 767a 776a 787a 836 830 845 840 951
Inpatient or Residential1 509a 542a 629 619 596 581a 539a 524a 531a 526a 547a 574a 606 642 737 708 683
Hospital 422a 467a 515 529 516 511a 469a 440a 447a 438a 463a 504a 547 588 666 622 608
Residential Treatment Center 224a 233a 299 229a 225a 199a 198a 213a 217a 240 238 206a 252 271 311 318 300
NONSPECIALTY MENTAL HEALTH
SERVICE2
nc nc nc nc nc nc nc 3,430a 3,465a 3,463a 3,649a 3,634a 3,736 3,691a 3,732a 3,810 3,977
Education2,3 nc nc nc nc nc nc nc 2,931a 2,957a 2,920a 3,157a 3,147a 3,229 3,206a 3,193a 3,231 3,444
School Social Worker, School Psychologist,
   or School Counselor
nc nc nc nc nc nc nc 2,286 2,214 2,188a 2,389 2,284 2,379 2,239 2,278 2,249 2,395
Special School or Program within a Regular
   School for Students with Emotional or
   Behavioral Problems
nc nc nc nc nc nc nc 975a 1,054a 1,063a 1,142a 1,218a 1,207a 1,357 1,319 1,345 1,461
General Medicine                                  
Pediatrician or Other Family Doctor 657a 732 840 810 694 692 710 605a 601a 619a 629a 686 700 668 708 805 767
Juvenile Justice                                  
Juvenile Detention Center, Prison, or Jail -- -- -- -- -- -- -- 109a 80a 103a 83a 59 63 53 53 45 48
Child Welfare                                  
Foster Care or Therapeutic Foster Care 157a 179a 158a 143a 129 114 118 92 108 140a 96 99 92 79 108 92 94
SPECIALTY MENTAL HEALTH SERVICES
AND EDUCATION, GENERAL MEDICINE
OR CHILD WELFARE SERVICES1,2,3
nc nc nc nc nc nc nc 1,226a 1,283a 1,328a 1,397a 1,490a 1,457a 1,408a 1,513a 1,615 1,706
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Mental health services for persons aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health service information were excluded.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
1 Because of revisions in 2013 to Specialty Mental Health Service estimates, these 2002 to 2012 estimates may differ from estimates published prior to the 2013 NSDUH.
2 Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to the 2009 NSDUH.
3 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this setting.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2018.
190522
Table 11.1B – Settings Where Mental Health Services Were Received in Past Year among Persons Aged 12 to 17: Percentages, 2002-2018
Setting Where Mental Health Service
Was Received
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
SPECIALTY MENTAL HEALTH SERVICE1 11.8a 12.4a 13.4a 13.4a 13.0a 12.4a 12.7a 12.0a 12.1a 12.6a 12.7a 13.6a 13.7a 13.3a 14.7a 14.8a 16.0
Outpatient 10.8a 11.3a 12.1a 12.1a 11.7a 11.2a 11.5a 10.9a 10.9a 11.5a 11.5a 12.5a 12.7a 12.0a 13.2a 13.6a 14.5
Private Therapist, Psychologist,
   Psychiatrist, Social Worker, or
   Counselor
9.2a 9.5a 10.1a 10.2a 9.6a 9.5a 9.8a 9.4a 9.4a 9.8a 9.8a 10.5a 11.0a 10.3a 11.5a 11.8 12.6
Mental Health Clinic or Center 2.5a 2.6a 2.9a 2.6a 2.3a 2.3a 2.3a 2.2a 2.3a 2.2a 2.5a 3.0a 3.1a 3.2a 3.8 4.0 4.0
Partial Day Hospital or Day Treatment
   Program
1.8 1.7 1.8 1.8 1.9 1.7 1.5a 1.4a 1.5a 1.6a 1.7 1.9 1.9 1.8 2.0 2.0 2.0
In-Home Therapist, Counselor, or Family
   Preservation Worker
2.8a 2.6a 3.0a 2.9a 2.9a 2.8a 2.9a 2.7a 2.8a 3.1a 3.1a 3.2a 3.4 3.4a 3.4 3.4 3.9
Inpatient or Residential1 2.1a 2.2a 2.5 2.5 2.4 2.3a 2.2a 2.1a 2.2a 2.1a 2.2a 2.3a 2.5 2.6 3.0 2.9 2.8
Hospital 1.7a 1.9a 2.1a 2.1 2.0a 2.0a 1.9a 1.8a 1.8a 1.8a 1.9a 2.0a 2.2 2.4 2.7 2.5 2.5
Residential Treatment Center 0.9a 0.9a 1.2 0.9a 0.9a 0.8a 0.8a 0.9a 0.9a 1.0 1.0a 0.8a 1.0 1.1 1.3 1.3 1.2
NONSPECIALTY MENTAL HEALTH
SERVICE2
nc nc nc nc nc nc nc 14.2a 14.5a 14.2a 15.0a 15.0a 15.4a 15.2a 15.4a 15.7 16.5
Education2,3 nc nc nc nc nc nc nc 12.1a 12.4a 11.9a 12.9a 13.0a 13.2 13.2a 13.1a 13.3 14.2
School Social Worker, School Psychologist,
   or School Counselor
nc nc nc nc nc nc nc 9.4 9.2 8.9a 9.7 9.4 9.7 9.2 9.3 9.2 9.9
Special School or Program within a Regular
   School for Students with Emotional or
   Behavioral Problems
nc nc nc nc nc nc nc 4.0a 4.4a 4.3a 4.7a 5.0a 4.9a 5.6 5.4a 5.5 6.0
General Medicine                                  
Pediatrician or Other Family Doctor 2.7a 2.9 3.4 3.2 2.8 2.8 2.9 2.5a 2.5a 2.5a 2.5a 2.8 2.9 2.7 2.9 3.3 3.1
Juvenile Justice                                  
Juvenile Detention Center, Prison, or Jail -- -- -- -- -- -- -- 0.4a 0.3a 0.4a 0.3a 0.2 0.3 0.2 0.2 0.2 0.2
Child Welfare                                  
Foster Care or Therapeutic Foster Care 0.6a 0.7a 0.6a 0.6a 0.5 0.5 0.5 0.4 0.4 0.6a 0.4 0.4 0.4 0.3 0.4 0.4 0.4
SPECIALTY MENTAL HEALTH SERVICES
AND EDUCATION, GENERAL MEDICINE
OR CHILD WELFARE SERVICES1,2,3
nc nc nc nc nc nc nc 5.0a 5.3a 5.4a 5.7a 6.1a 5.9a 5.7a 6.2a 6.6 7.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Mental health services for persons aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health service information were excluded.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
1 Because of revisions in 2013 to Specialty Mental Health Service estimates, these 2002 to 2012 estimates may differ from estimates published prior to the 2013 NSDUH.
2 Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to the 2009 NSDUH.
3 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this setting.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2018.
190418
Table 11.2A – Major Depressive Episode in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2004-2018
Demographic Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
TOTAL 2,225a 2,191a 1,970a 2,016a 2,027a 1,954a 1,911a 2,011a 2,213a 2,587a 2,751a 3,031a 3,089a 3,214a 3,482
AGE GROUP                              
12-13 445a 417a 383a 337a 366a 330a 330a 312a 420a 470a 548 587 548 516a 632
14-15 783a 811a 684a 705a 706a 741a 706a 710a 844a 1,025a 986a 1,163 1,115 1,200 1,250
16-17 997a 964a 902a 974a 955a 883a 876a 989a 950a 1,091a 1,217a 1,281a 1,427 1,498 1,600
GENDER                              
Male 637a 571a 539a 586a 540a 577a 536a 566a 581a 657a 710a 725a 786a 845 946
Female 1,588a 1,620a 1,431a 1,430a 1,487a 1,377a 1,375a 1,446a 1,632a 1,930a 2,042a 2,306a 2,303a 2,369 2,537
HISPANIC ORIGIN AND RACE                              
Not Hispanic or Latino 1,848a 1,802a 1,614a 1,691a 1,681a 1,594a 1,537a 1,586a 1,648a 1,970a 2,123a 2,323a 2,366a 2,419 2,601
White 1,413a 1,390a 1,220a 1,284a 1,266a 1,180a 1,186a 1,167a 1,231a 1,449a 1,578a 1,742 1,781 1,785 1,905
Black or African American 287 288 245a 292 261 285 236a 238a 269 289 306 302 301 313 334
AIAN 13 10 12 7a 13 9 10 15 7a 7a 11 * 16 24 23
NHOPI * * * * * * 1 * * * * * * * *
Asian 82a 63a 77a 66a 73a 73a 57a 90a 49a 123 124 118a 152 145 189
Two or More Races 51a 41a 52a 41a 59a 41a 48a 75a 81a 95a 93a 121 109 138 137
Hispanic or Latino 377a 389a 356a 325a 347a 360a 374a 425a 566a 617a 628a 708a 724a 795 882
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2018.
190418
Table 11.2B – Major Depressive Episode in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2004-2018
Demographic Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
TOTAL 9.0a 8.8a 7.9a 8.2a 8.3a 8.1a 8.0a 8.2a 9.1a 10.7a 11.4a 12.5a 12.8a 13.3a 14.4
AGE GROUP                              
12-13 5.4a 5.2a 4.9a 4.3a 4.9a 4.6a 4.3a 4.1a 5.4a 6.1a 7.2 7.8 7.3 6.9a 8.4
14-15 9.2a 9.5a 7.9a 8.4a 8.5a 8.8a 9.0a 8.6a 10.2a 12.4a 11.9a 13.8 13.3a 14.5 15.3
16-17 12.3a 11.5a 10.7a 11.5a 11.2a 10.4a 10.6a 11.7a 11.4a 13.2a 14.6a 15.5a 17.2 17.7 19.0
GENDER                              
Male 5.0a 4.5a 4.2a 4.6a 4.3a 4.7a 4.4a 4.5a 4.7a 5.3a 5.7a 5.8a 6.4a 6.8 7.7
Female 13.1a 13.3a 11.8a 11.9a 12.5a 11.7a 11.9a 12.1a 13.7a 16.2a 17.3a 19.5a 19.4a 20.0 21.5
HISPANIC ORIGIN AND RACE                              
Not Hispanic or Latino 8.9a 8.7a 7.9a 8.4a 8.5a 8.2a 8.1a 8.3a 8.7a 10.4a 11.3a 12.5a 12.8a 13.1a 14.2
White 9.2a 9.1a 8.2a 8.7a 8.8a 8.4a 8.6a 8.6a 9.1a 10.9a 12.0a 13.4a 13.8 14.0 15.1
Black or African American 7.7a 7.6a 6.4a 7.8a 7.1a 7.9a 6.8a 7.0a 7.9a 8.6 9.1 9.0 9.1 9.5 10.3
AIAN 7.8 6.1a 9.3 4.6a 10.1 7.5 7.4 11.4 5.2a 4.5a 6.9 * 11.5 16.3 15.2
NHOPI * * * * * * 1.8 * * * * * * * *
Asian 8.3a 6.0a 7.7a 6.6a 7.7a 7.6a 5.5a 7.6a 4.2a 10.2 10.4 9.7 11.9 11.3 13.6
Two or More Races 11.7a 10.5a 13.0 9.9a 12.0a 8.0a 9.4a 10.6a 11.3a 13.0 12.5a 15.6 13.8 16.9 17.7
Hispanic or Latino 9.1a 9.1a 8.0a 7.1a 7.5a 7.7a 7.8a 8.1a 10.5a 11.4a 11.5a 12.6a 12.7a 13.8 15.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2018.
190418
Table 11.3A – Major Depressive Episode with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2006-2018
Demographic Characteristic 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
TOTAL 1,358a 1,371a 1,460a 1,404a 1,350a 1,388a 1,544a 1,868a 1,990a 2,129a 2,168a 2,265 2,423
AGE GROUP                          
12-13 211a 200a 239a 235a 232a 218a 285a 314 375 388 354 332 382
14-15 518a 500a 505a 521a 479a 487a 590a 752a 707a 826 789 861 891
16-17 629a 671a 716a 648a 639a 683a 669a 801a 909a 915a 1,025 1,072 1,150
GENDER                          
Male 335a 386a 359a 391a 395a 397a 373a 435a 461a 477a 539 581 628
Female 1,023a 986a 1,101a 1,013a 954a 991a 1,172a 1,432a 1,529a 1,652 1,629a 1,684 1,795
HISPANIC ORIGIN AND RACE                          
Not Hispanic or Latino 1,118a 1,141a 1,226a 1,150a 1,093a 1,113a 1,152a 1,425a 1,540a 1,651a 1,703 1,694 1,841
White 871a 873a 944a 858a 853a 799a 883a 1,046a 1,167a 1,258 1,290 1,256 1,354
Black or African American 150a 193 171 204 157a 183 164a 207 214 198 196 233 225
AIAN 9 4 8 5 7 13 4 6 8 * 8 6 *
NHOPI * * * * * * * * * * * * *
Asian 54a 39a 44a 48a 44a 60a 30a 98 80 67a 118 101 127
Two or More Races 32a 32a 50a 31a 30a 57a 64a 61a 66a 98 86 89 109
Hispanic or Latino 240a 230a 233a 254a 257a 275a 392a 442a 450a 477a 465a 571 582
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2018.
190418
Table 11.3B – Major Depressive Episode with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2006-2018
Demographic Characteristic 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
TOTAL 5.5a 5.5a 6.0a 5.8a 5.7a 5.7a 6.3a 7.7a 8.2a 8.8a 9.0a 9.4 10.0
AGE GROUP                          
12-13 2.7a 2.5a 3.2a 3.2a 3.0a 2.8a 3.7a 4.1a 4.9 5.1 4.7 4.4 5.1
14-15 6.0a 6.0a 6.1a 6.2a 6.1a 5.9a 7.1a 9.1a 8.5a 9.8 9.4a 10.4 10.9
16-17 7.5a 7.9a 8.4a 7.7a 7.7a 8.1a 8.0a 9.7a 10.9a 11.1a 12.4 12.7 13.7
GENDER                          
Male 2.6a 3.0a 2.9a 3.2a 3.2a 3.2a 3.0a 3.5a 3.7a 3.8a 4.4 4.7 5.1
Female 8.4a 8.2a 9.3a 8.6a 8.2a 8.3a 9.8a 12.0a 13.0a 14.0 13.7a 14.2 15.2
HISPANIC ORIGIN AND RACE                          
Not Hispanic or Latino 5.5a 5.7a 6.2a 5.9a 5.7a 5.8a 6.1a 7.6a 8.2a 8.9a 9.2 9.2 10.1
White 5.8a 5.9a 6.5a 6.1a 6.2a 5.9a 6.5a 7.8a 8.9a 9.7 10.0 9.8 10.7
Black or African American 3.9a 5.1a 4.6a 5.7 4.5a 5.4 4.8a 6.2 6.4 5.9 6.0 7.1 6.9
AIAN 6.6 2.6 6.5 4.3 5.4 9.8 2.6 3.8 4.9 * 5.7 3.9 *
NHOPI * * * * * * * * * * * * *
Asian 5.3 3.9a 4.7a 5.0a 4.3a 5.0a 2.6a 8.1 6.6 5.5a 9.3 7.9 9.2
Two or More Races 8.0a 7.8a 10.2 6.0a 5.9a 8.1a 9.0a 8.4a 8.9a 12.6 10.9 10.9 14.2
Hispanic or Latino 5.4a 5.1a 5.1a 5.4a 5.4a 5.2a 7.3a 8.2a 8.2a 8.5 8.2a 9.9 10.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2018.
190418
Table 11.4A – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with Major Depressive Episode in Past Year, by Demographic Characteristics: Numbers in Thousands, 2004-2018
Demographic Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
TOTAL 895a 822a 760a 782a 764a 673a 721a 769a 813a 977a 1,122a 1,186a 1,249a 1,330 1,432
AGE GROUP                              
12-13 169a 136a 133a 137a 122a 98a 106a 112a 127a 181a 194 185a 189a 193 251
14-15 278a 329a 263a 259a 236a 244a 271a 258a 307a 376a 394a 472 455 453 514
16-17 448a 357a 364a 386a 405a 331a 343a 400a 379a 420a 535a 530a 605 684 667
GENDER                              
Male 239a 193a 189a 214a 183a 168a 171a 199a 163a 193a 265a 262a 260a 274a 351
Female 656a 629a 571a 568a 581a 505a 549a 570a 650a 784a 857a 924a 989 1,056 1,081
HISPANIC ORIGIN AND RACE                              
Not Hispanic or Latino 756a 700a 634a 691a 658a 555a 577a 645a 642a 753a 918a 936a 1,008 1,072 1,100
White 633a 544a 502a 545a 545a 444a 487a 482a 500a 598a 723a 702a 799 847 870
Black or African American 82 113 70a 116 85 67a 54a 97 90 83 123 127 102 110 115
AIAN * * * * * * * * * * * * * * *
NHOPI * * * * * * * * * * * * * * *
Asian * * * * * * * * * * * * * * *
Two or More Races * * * * * * * * * * * 55 * 62 48
Hispanic or Latino 139a 122a 126a 91a 105a 118a 144a 125a 171a 224a 204a 251 241a 258 332
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2018.
190418
Table 11.4B – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with Major Depressive Episode in Past Year, by Demographic Characteristics: Percentages, 2004-2018
Demographic Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
TOTAL 40.3 37.8 38.8 39.0 37.7 34.6a 37.8 38.4 37.0a 38.1 41.2 39.3 40.9 41.5 41.4
AGE GROUP                              
12-13 38.2 32.9 35.1 41.5 33.5 30.0a 32.5 36.3 30.7a 39.1 35.9 31.9a 35.3 37.6 40.7
14-15 35.5 41.1 38.4 36.8 33.6a 33.2a 38.4 36.3 36.6 37.2 40.1 40.6 41.3 37.9 41.2
16-17 45.0 37.1 40.7 39.8 42.4 37.5 39.3 40.5 40.0 38.6 44.4 41.5 42.6 45.8 41.8
GENDER                              
Male 37.7 34.1 35.3 36.7 34.0 29.2a 32.0 35.3 28.3a 29.7a 37.7 36.3 33.5 32.5 37.5
Female 41.3 39.0 40.2 40.0 39.1 36.9a 40.1 39.5 40.1 40.9 42.4 40.3 43.4 44.8 42.9
HISPANIC ORIGIN AND RACE                              
Not Hispanic or Latino 41.0 39.0 39.5 41.1 39.3 35.0a 37.6a 40.7 39.0 38.5a 43.5 40.5 42.9 44.4 42.6
White 44.9 39.3a 41.3 42.7 43.1 37.7a 41.1 41.4 40.7a 41.6 46.1 40.6a 45.1 47.5 46.1
Black or African American 28.9 39.3 29.1 39.7 32.4 23.9a 23.0a 41.0 33.5 28.6 40.6 42.0 34.5 35.1 34.6
AIAN * * * * * * * * * * * * * * *
NHOPI * * * * * * * * * * * * * * *
Asian * * * * * * * * * * * * * * *
Two or More Races * * * * * * * * * * * 46.7 * 44.8 34.8
Hispanic or Latino 36.8 31.8 35.9 28.2a 30.4 33.0 38.4 29.4 30.8 36.9 33.1 35.5 34.1 32.7 37.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2018.
190418
Table 11.5A – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year, by Demographic Characteristics: Numbers in Thousands, 2006-2018
Demographic Characteristic 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
TOTAL 627a 601a 622a 542a 554a 602a 633a 832a 882a 945a 1,001 1,074 1,133
AGE GROUP                          
12-13 92a 85a 91a 78a 66a 91a 91a 150 143 142 131 153 177
14-15 232a 216a 194a 184a 215a 200a 239a 320a 307a 374 369 364 406
16-17 304a 300a 336a 280a 273a 311a 302a 363a 433a 429a 501 558 550
GENDER                          
Male 134a 154a 132a 132a 132a 147a 127a 157a 189a 206a 208a 208a 274
Female 493a 447a 489a 410a 422a 455a 506a 675a 693a 739a 793 866 859
HISPANIC ORIGIN AND RACE                          
Not Hispanic or Latino 535a 534a 550a 443a 448a 502a 506a 645a 725a 755a 827 868 882
White 432a 439a 461a 352a 380a 379a 403a 504a 572a 563a 668 679 695
Black or African American 53a 72 65 58 42a 82 56a 72 99 97 71 97 90
AIAN * * * * * * * * * * * * *
NHOPI * * * * * * * * * * * * *
Asian * * * * * * * * * * * * *
Two or More Races * * * * * * * * * * * * *
Hispanic or Latino 92a 67a 72a 99a 106a 100a 127a 187 158a 190 174a 206 251
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2018.
190418
Table 11.5B – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year, by Demographic Characteristics: Percentages, 2006-2018
Demographic Characteristic 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
TOTAL 46.5 43.9 42.6 38.8a 41.1a 43.5 41.0a 45.0 44.7 44.6 46.7 47.5 46.9
AGE GROUP                          
12-13 44.1 42.3 38.3 33.8a 28.7a 42.3 32.0a 48.5 38.7 37.0a 37.6 46.2 47.2
14-15 44.8 43.2 38.6 35.6a 45.0 41.0 40.5 43.2 43.4 45.4 47.5 42.3 45.6
16-17 48.8 44.9 46.9 43.2 42.7 45.5 45.4 45.3 48.1 47.1 49.2 52.0 47.8
GENDER                          
Male 40.1 40.2 36.9 34.0a 33.4a 37.3 34.4a 36.4 41.2 43.1 39.0 35.8 43.7
Female 48.6 45.4 44.5 40.7a 44.3 45.9 43.2 47.6 45.7 45.1 49.3 51.5 48.1
HISPANIC ORIGIN AND RACE                          
Not Hispanic or Latino 48.0 46.8 44.9 38.7a 41.1a 45.2 43.9 45.6 47.3 46.0 48.9 51.3 48.1
White 49.8 50.4 48.9 41.1a 44.5a 47.4 45.7a 48.6 49.2 45.0a 52.1 54.1 51.6
Black or African American 35.5 37.4 38.0 28.9 26.9a 44.6 34.4 34.9 46.9 48.8 37.1 41.6 40.1
AIAN * * * * * * * * * * * * *
NHOPI * * * * * * * * * * * * *
Asian * * * * * * * * * * * * *
Two or More Races * * * * * * * * * * * * *
Hispanic or Latino 39.4 29.4a 30.8a 39.3 41.3 36.4 32.6a 43.1 35.6 40.0 38.4 36.1 43.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2018.
190418
Table 11.6A – Substance Use in Past Year and Past Month among Persons Aged 12 to 17 with Major Depressive Episode in Past Year: Numbers in Thousands, 2004-2018
Substance 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
PAST YEAR USE                              
Illicit Drugs nc nc nc nc nc nc nc nc nc nc nc 955a 979a 942a 1,138
Marijuana 601a 553a 483a 473a 485a 472a 481a 523a 547a 664a 664a 675a 751a 724a 878
Cocaine 66a 73a 64 69a 61 43 46 54 53 28 41 34 35 37 35
Crack 15a 12a 16a 17a 12a 9a 9a 11a 7 2 11a * 4 2 0
Heroin 9 10 11 6 9 10 10 11 11 7 12 5 3 6 3
Hallucinogens nc nc nc nc nc nc nc nc nc nc nc 129 127 145 112
LSD 36 38 18a 16a 28a 43 24a 30a 40 29a 48 63 41 72 62
PCP 21 16 11 8 20a 12 8 12 9 6 11 2 6 12 6
Ecstasy nc nc nc nc nc nc nc nc nc nc nc 45 59 47 46
Inhalants nc nc nc nc nc nc nc nc nc nc nc 193 159 145 178
Methamphetamine nc nc nc nc nc nc nc nc nc nc nc 14 6 14 8
Misuse of Psychotherapeutics nc nc nc nc nc nc nc nc nc nc nc 370 411 369 375
Pain Relievers nc nc nc nc nc nc nc nc nc nc nc 236 283a 210 214
Stimulants nc nc nc nc nc nc nc nc nc nc nc 166 142 158 126
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc nc nc 117a 168 167 168
Tranquilizers nc nc nc nc nc nc nc nc nc nc nc 103a 149 164 153
Sedatives nc nc nc nc nc nc nc nc nc nc nc 26 43 22 34
Benzodiazepines nc nc nc nc nc nc nc nc nc nc nc 96a 142 154 145
Opioids nc nc nc nc nc nc nc nc nc nc nc 236 285a 212 214
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc nc nc 563 553 515 547
PAST MONTH USE                              
Alcohol 632 606 523 553 509 473 460a 482 503 490 556 524 508 524 558
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc nc nc 288 268 293 295
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc nc nc 51a 52a 39 22
Cigarette Use 508a 450a 378a 388a 354a 336a 302a 317a 284a 288a 254 241 239 214 212
Daily Cigarette Use 171a 116a 102a 96a 75a 70a 59a 81a 61a 46a 45 55a 27 25 23
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2018.
190418
Table 11.6B – Substance Use in Past Year and Past Month among Persons Aged 12 to 17 with Major Depressive Episode in Past Year: Percentages, 2004-2018
Substance 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
PAST YEAR USE                              
Illicit Drugs nc nc nc nc nc nc nc nc nc nc nc 31.5 31.7 29.3 32.7
Marijuana 27.0 25.2 24.5 23.5 23.9 24.2 25.2 26.0 24.7 25.7 24.1 22.3 24.3 22.5 25.2
Cocaine 3.0a 3.4a 3.3a 3.4a 3.0a 2.2a 2.4a 2.7a 2.4a 1.1 1.5 1.1 1.1 1.1 1.0
Crack 0.7a 0.6a 0.8a 0.9a 0.6a 0.5a 0.5a 0.5a 0.3 0.1 0.4a * 0.1 0.1 0.0
Heroin 0.4 0.4 0.5a 0.3 0.4 0.5a 0.5a 0.5a 0.5a 0.3 0.4 0.2 0.1 0.2 0.1
Hallucinogens nc nc nc nc nc nc nc nc nc nc nc 4.2 4.1 4.5 3.2
LSD 1.6 1.7 0.9a 0.8a 1.4 2.2 1.2 1.5 1.8 1.1 1.8 2.1 1.3 2.2 1.8
PCP 0.9a 0.7a 0.6 0.4 1.0a 0.6 0.4 0.6 0.4 0.2 0.4 0.1 0.2 0.4 0.2
Ecstasy nc nc nc nc nc nc nc nc nc nc nc 1.5 1.9 1.5 1.3
Inhalants nc nc nc nc nc nc nc nc nc nc nc 6.4 5.1 4.5 5.1
Methamphetamine nc nc nc nc nc nc nc nc nc nc nc 0.5 0.2 0.4 0.2
Misuse of Psychotherapeutics nc nc nc nc nc nc nc nc nc nc nc 12.2 13.3a 11.5 10.8
Pain Relievers nc nc nc nc nc nc nc nc nc nc nc 7.8 9.2a 6.5 6.1
Stimulants nc nc nc nc nc nc nc nc nc nc nc 5.5a 4.6 4.9 3.6
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc nc nc 3.9 5.5 5.2 4.8
Tranquilizers nc nc nc nc nc nc nc nc nc nc nc 3.4 4.8 5.1 4.4
Sedatives nc nc nc nc nc nc nc nc nc nc nc 0.8 1.4 0.7 1.0
Benzodiazepines nc nc nc nc nc nc nc nc nc nc nc 3.2 4.6 4.8 4.2
Opioids nc nc nc nc nc nc nc nc nc nc nc 7.8 9.2a 6.6 6.1
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc nc nc 18.6 17.9 16.0 15.7
PAST MONTH USE                              
Alcohol 28.4a 27.6a 26.6a 27.4a 25.1a 24.2a 24.0a 23.9a 22.7a 18.9a 20.2a 17.3 16.5 16.3 16.0
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc nc nc 9.5 8.7 9.1 8.5
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc nc nc 1.7a 1.7a 1.2 0.6
Cigarette Use 22.8a 20.5a 19.2a 19.2a 17.4a 17.2a 15.8a 15.8a 12.8a 11.1a 9.2a 8.0 7.8 6.7 6.1
Daily Cigarette Use 7.7a 5.3a 5.2a 4.8a 3.7a 3.6a 3.1a 4.0a 2.7a 1.8a 1.6a 1.8a 0.9 0.8 0.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2018.
190418
Table 11.7A – Substance Use in Past Year and Past Month among Persons Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year: Numbers in Thousands, 2006-2018
Substance 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
PAST YEAR USE                          
Illicit Drugs nc nc nc nc nc nc nc nc nc 774 757a 720a 885
Marijuana 362a 339a 384a 366a 327a 375a 414a 495a 510a 545a 572a 547a 678
Cocaine 47 54a 48 35 35 36 45 17 32 32 30 27 27
Crack 10a 17a 5a 6a 7a 11a 7 2 6 * 4 2 0
Heroin 9 6 8 6 9 8 11 7 12 2 3 4 3
Hallucinogens nc nc nc nc nc nc nc nc nc 116 102 122 96
LSD 13a 13a 23a 30 20a 23a 36 19a 45 56 31 58 52
PCP 10 5 16 6 4 7 8 6 11 2 6 11 6
Ecstasy nc nc nc nc nc nc nc nc nc 43 46 42 42
Inhalants nc nc nc nc nc nc nc nc nc 151 124 119 145
Methamphetamine nc nc nc nc nc nc nc nc nc 10 5 14 6
Misuse of Psychotherapeutics nc nc nc nc nc nc nc nc nc 325 349 285 301
Pain Relievers nc nc nc nc nc nc nc nc nc 201 237a 170 172
Stimulants nc nc nc nc nc nc nc nc nc 148 130 122 106
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc 103a 148 131 151
Tranquilizers nc nc nc nc nc nc nc nc nc 89a 131 127 136
Sedatives nc nc nc nc nc nc nc nc nc 25 41 19 30
Benzodiazepines nc nc nc nc nc nc nc nc nc 82a 125 119 129
Opioids nc nc nc nc nc nc nc nc nc 201 238a 172 172
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc 477 450 406 435
PAST MONTH USE                          
Alcohol 386 404 385 372 318a 331a 370 365 421 396 373 398 433
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc 228 199 220 238
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc 49a 40a 29 17
Cigarette Use 290a 285a 275a 276a 219 225 217 221 203 213 194 168 177
Daily Cigarette Use 83a 75a 56a 55a 46a 58a 44a 32 40 50a 19 18 17
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2018.
190418
Table 11.7B – Substance Use in Past Year and Past Month among Persons Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year: Percentages, 2006-2018
Substance 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
PAST YEAR USE                          
Illicit Drugs nc nc nc nc nc nc nc nc nc 36.3 34.9 31.8a 36.5
Marijuana 26.6 24.7 26.3 26.0 24.3 27.0 26.8 26.5 25.6 25.6 26.4 24.1a 28.0
Cocaine 3.5a 4.0a 3.3a 2.5a 2.6a 2.6a 2.9a 0.9 1.6 1.5 1.4 1.2 1.1
Crack 0.8a 1.2a 0.4a 0.5a 0.5a 0.8a 0.4 0.1 0.3 * 0.2 0.1 0.0
Heroin 0.6 0.5 0.6 0.4 0.6 0.6 0.7a 0.4 0.6 0.1 0.1 0.2 0.1
Hallucinogens nc nc nc nc nc nc nc nc nc 5.5 4.7 5.4 4.0
LSD 0.9a 0.9a 1.6 2.1 1.5 1.7 2.3 1.0a 2.2 2.6 1.4 2.6 2.1
PCP 0.8 0.4 1.1a 0.4 0.3 0.5 0.5 0.3 0.5 0.1 0.3 0.5 0.2
Ecstasy nc nc nc nc nc nc nc nc nc 2.0 2.1 1.9 1.7
Inhalants nc nc nc nc nc nc nc nc nc 7.1 5.7 5.2 6.0
Methamphetamine nc nc nc nc nc nc nc nc nc 0.5 0.2 0.6 0.3
Misuse of Psychotherapeutics nc nc nc nc nc nc nc nc nc 15.3 16.1a 12.6 12.4
Pain Relievers nc nc nc nc nc nc nc nc nc 9.4 10.9a 7.5 7.1
Stimulants nc nc nc nc nc nc nc nc nc 6.9a 6.0 5.4 4.4
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc 4.8 6.8 5.8 6.2
Tranquilizers nc nc nc nc nc nc nc nc nc 4.2 6.0 5.6 5.6
Sedatives nc nc nc nc nc nc nc nc nc 1.2 1.9 0.8 1.2
Benzodiazepines nc nc nc nc nc nc nc nc nc 3.8 5.8 5.2 5.3
Opioids nc nc nc nc nc nc nc nc nc 9.4 11.0a 7.6 7.1
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc 22.4a 20.8 17.9 18.0
PAST MONTH USE                          
Alcohol 28.4a 29.5a 26.4a 26.5a 23.6a 23.8a 24.0a 19.5 21.1 18.6 17.2 17.6 17.9
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc 10.7 9.2 9.7 9.8
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc 2.3a 1.8a 1.3 0.7
Cigarette Use 21.3a 20.8a 18.8a 19.7a 16.2a 16.2a 14.1a 11.8a 10.2a 10.0a 8.9 7.4 7.3
Daily Cigarette Use 6.1a 5.5a 3.8a 3.9a 3.4a 4.2a 2.9a 1.7a 2.0a 2.3a 0.9 0.8 0.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2018.
190418
Table 11.8A – Substance Use in Past Year and Past Month among Persons Aged 12 to 17 with No Major Depressive Episode in Past Year: Numbers in Thousands, 2004-2018
Substance 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
PAST YEAR USE                              
Illicit Drugs nc nc nc nc nc nc nc nc nc nc nc 3,251a 2,823 3,010 2,888
Marijuana 2,998a 2,763a 2,803a 2,629a 2,693a 2,810a 2,836a 2,962a 2,746a 2,561a 2,479a 2,366 2,136 2,283 2,164
Cocaine 335a 335a 337a 302a 238a 196a 178a 165a 123a 93 115a 115a 91 87 66
Crack 44a 37a 57a 45a 22a 18a 9a 18a 12 7 5 5 4 14 1
Heroin 37a 23a 26a 15a 27a 25a 18 36a 20 20a 13 14 9 7 5
Hallucinogens nc nc nc nc nc nc nc nc nc nc nc 371a 308 346a 254
LSD 117 108 86a 108 150 97 103 113 106 108 163 177 157 173 136
PCP 47a 64a 47a 48a 40a 35a 26a 26a 36a 20a 22a 29a 12 10 7
Ecstasy nc nc nc nc nc nc nc nc nc nc nc 151a 111 121 80
Inhalants nc nc nc nc nc nc nc nc nc nc nc 457 378 418 460
Methamphetamine nc nc nc nc nc nc nc nc nc nc nc 22 23 31 32
Misuse of Psychotherapeutics nc nc nc nc nc nc nc nc nc nc nc 1,044a 851 824 767
Pain Relievers nc nc nc nc nc nc nc nc nc nc nc 700a 556a 526 444
Stimulants nc nc nc nc nc nc nc nc nc nc nc 305a 275 280 231
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc nc nc 315 285 313 275
Tranquilizers nc nc nc nc nc nc nc nc nc nc nc 277 260 282 253
Sedatives nc nc nc nc nc nc nc nc nc nc nc 73a 50 50 29
Benzodiazepines nc nc nc nc nc nc nc nc nc nc nc 260 250 280 243
Opioids nc nc nc nc nc nc nc nc nc nc nc 710a 563a 526 448
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc nc nc 1,610a 1,335 1,373 1,284
PAST MONTH USE                              
Alcohol 3,741a 3,515a 3,635a 3,413a 3,088a 3,114a 2,793a 2,759a 2,660a 2,316a 2,219a 1,823a 1,726 1,862a 1,618
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc nc nc 1,127a 901 990a 843
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc nc nc 165a 132 129 105
Cigarette Use 2,420a 2,221a 2,214a 2,047a 1,858a 1,825a 1,659a 1,557a 1,294a 1,042a 900a 755a 574a 538a 427
Daily Cigarette Use 628a 568a 583a 527a 417a 433a 388a 349a 285a 212a 229a 141a 94 68 73
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2018.
190418
Table 11.8B – Substance Use in Past Year and Past Month among Persons Aged 12 to 17 with No Major Depressive Episode in Past Year: Percentages, 2004-2018
Substance 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
PAST YEAR USE                              
Illicit Drugs nc nc nc nc nc nc nc nc nc nc nc 15.3a 13.4 14.3 14.0
Marijuana 13.3a 12.1a 12.2a 11.6a 12.0a 12.7a 12.9a 13.2a 12.4a 11.8a 11.6a 11.1 10.1 10.9 10.5
Cocaine 1.5a 1.5a 1.5a 1.3a 1.1a 0.9a 0.8a 0.7a 0.6a 0.4 0.5a 0.5a 0.4 0.4 0.3
Crack 0.2a 0.2a 0.2a 0.2a 0.1a 0.1a 0.0a 0.1a 0.1 0.0 0.0 0.0 0.0 0.1 0.0
Heroin 0.2a 0.1a 0.1a 0.1 0.1a 0.1a 0.1 0.2a 0.1 0.1a 0.1 0.1 0.0 0.0 0.0
Hallucinogens nc nc nc nc nc nc nc nc nc nc nc 1.7a 1.5 1.6a 1.2
LSD 0.5 0.5 0.4a 0.5 0.7 0.4a 0.5 0.5 0.5 0.5 0.8 0.8 0.7 0.8 0.7
PCP 0.2a 0.3a 0.2a 0.2a 0.2a 0.2a 0.1a 0.1a 0.2a 0.1 0.1a 0.1a 0.1 0.0 0.0
Ecstasy nc nc nc nc nc nc nc nc nc nc nc 0.7a 0.5 0.6 0.4
Inhalants nc nc nc nc nc nc nc nc nc nc nc 2.2 1.8a 2.0 2.2
Methamphetamine nc nc nc nc nc nc nc nc nc nc nc 0.1 0.1 0.1 0.2
Misuse of Psychotherapeutics nc nc nc nc nc nc nc nc nc nc nc 4.9a 4.0 3.9 3.7
Pain Relievers nc nc nc nc nc nc nc nc nc nc nc 3.3a 2.6a 2.5 2.2
Stimulants nc nc nc nc nc nc nc nc nc nc nc 1.4 1.3 1.3 1.1
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc nc nc 1.5 1.3 1.5 1.3
Tranquilizers nc nc nc nc nc nc nc nc nc nc nc 1.3 1.2 1.3 1.2
Sedatives nc nc nc nc nc nc nc nc nc nc nc 0.3a 0.2 0.2 0.1
Benzodiazepines nc nc nc nc nc nc nc nc nc nc nc 1.2 1.2 1.3 1.2
Opioids nc nc nc nc nc nc nc nc nc nc nc 3.3a 2.7a 2.5 2.2
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc nc nc 7.6a 6.3 6.5 6.2
PAST MONTH USE                              
Alcohol 16.5a 15.4a 15.8a 15.0a 13.8a 14.1a 12.8a 12.3a 12.0a 10.7a 10.3a 8.6 8.2 8.9a 7.8
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc nc nc 5.3a 4.3 4.7 4.1
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc nc nc 0.8a 0.6 0.6 0.5
Cigarette Use 10.7a 9.8a 9.7a 9.0a 8.3a 8.2a 7.6a 7.0a 5.8a 4.8a 4.2a 3.6a 2.7a 2.6a 2.1
Daily Cigarette Use 2.8a 2.5a 2.5a 2.3a 1.9a 2.0a 1.8a 1.6a 1.3a 1.0a 1.1a 0.7a 0.4 0.3 0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2018.
190419
Table 11.9A – Major Depressive Episode in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Gender: Numbers in Thousands, 2015-2018
Substance Use Disorder Status/Gender 2015 2016 2017 2018
SUBSTANCE USE DISORDER 350 333 345 358
Male 87 72a 101 114
Female 263 261 244 244
Illicit Drug Use Disorder 241 236 260 279
Male 57 59 80 87
Female 184 177 180 193
Alcohol Use Disorder 202 182 164 159
Male 51 27 47 *
Female 151 156a 118 108
NO SUBSTANCE USE DISORDER 2,681a 2,756a 2,869a 3,124
Male 638a 714 744 832
Female 2,043a 2,042a 2,125 2,292
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2018.
190419
Table 11.9B – Major Depressive Episode in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Gender: Percentages, 2015-2018
Substance Use Disorder Status/Gender 2015 2016 2017 2018
SUBSTANCE USE DISORDER 29.1a 33.0a 35.9 40.6
Male 14.8a 15.0a 22.6 26.4
Female 42.8a 49.5 47.6 54.4
Illicit Drug Use Disorder 28.9a 31.8a 36.2 42.8
Male 13.7a 15.4a 22.7 25.9
Female 43.9a 49.0a 49.1a 60.5
Alcohol Use Disorder 33.0 39.5 38.5 40.8
Male 17.4 14.6 26.7 *
Female 47.0 55.8 46.8 48.1
NO SUBSTANCE USE DISORDER 11.6a 11.9a 12.3a 13.4
Male 5.4a 6.0 6.2 7.0
Female 18.2a 18.0a 18.7 20.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2018.
190419
Table 11.10A – Major Depressive Episode with Severe Impairment in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Gender: Numbers in Thousands, 2015-2018
Substance Use Disorder Status/Gender 2015 2016 2017 2018
SUBSTANCE USE DISORDER 303 278 276 288
Male 70 56 81 82
Female 232 222 195 207
Illicit Drug Use Disorder 219 202 215 227
Male 48 44 66 60
Female 172 158 149 167
Alcohol Use Disorder 172 152 124 132
Male 43 22 34 *
Female 129 130 90 93
NO SUBSTANCE USE DISORDER 1,826a 1,890a 1,989 2,135
Male 407a 483 500 546
Female 1,419 1,407a 1,489 1,588
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2018.
190419
Table 11.10B – Major Depressive Episode with Severe Impairment in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Gender: Percentages, 2015-2018
Substance Use Disorder Status/Gender 2015 2016 2017 2018
SUBSTANCE USE DISORDER 25.2a 27.5 28.8 32.7
Male 12.0 11.6a 18.1 18.9
Female 37.8 42.2 38.1 46.0
Illicit Drug Use Disorder 26.3a 27.3a 29.9 34.8
Male 11.5 11.7 18.8 18.0
Female 40.9a 43.6 40.6a 52.4
Alcohol Use Disorder 28.2 32.8 29.1 33.9
Male 14.7 11.9 19.6 *
Female 40.2 46.5 35.7 41.3
NO SUBSTANCE USE DISORDER 7.9a 8.2a 8.5 9.2
Male 3.4a 4.1 4.2 4.6
Female 12.6 12.4a 13.1 14.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2018.
190418
Table 11.11A – Substance Use Disorder, Illicit Drug Use Disorder, or Alcohol Use Disorder in Past Year among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Gender: Numbers in Thousands, 2015-2018
Substance Use Disorder/ MDE Status/Gender 2015 2016 2017 2018
SUBSTANCE USE DISORDER        
MDE 350 333 345 358
Male 87 72a 101 114
Female 263 261 244 244
MDE WITH SEVERE IMPAIRMENT 303 278 276 288
Male 70 56 81 82
Female 232 222 195 207
NO MDE 854a 676a 615 523
Male 502a 411a 346 318
Female 352a 265a 268 205
ILLICIT DRUG USE DISORDER        
MDE 241 236 260 279
Male 57 59 80 87
Female 184 177 180 193
MDE WITH SEVERE IMPAIRMENT 219 202 215 227
Male 48 44 66 60
Female 172 158 149 167
NO MDE 593a 506a 459 374
Male 357a 321 272 248
Female 235a 185a 186a 126
ALCOHOL USE DISORDER        
MDE 202 182 164 159
Male 51 27 47 50
Female 151 156a 118 108
MDE WITH SEVERE IMPAIRMENT 172 152 124 132
Male 43 22 34 39
Female 129 130 90 93
NO MDE 411a 279 262 231
Male 240a 156 129 114
Female 171a 123 134 117
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2018.
190418
Table 11.11B – Substance Use Disorder, Illicit Drug Use Disorder, or Alcohol Use Disorder in Past Year among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Gender: Percentages, 2015-2018
Substance Use Disorder/ MDE Status/Gender 2015 2016 2017 2018
SUBSTANCE USE DISORDER        
MDE 11.6 10.8 10.7 10.3
Male 12.0 9.2 12.0 12.0
Female 11.4 11.3 10.3 9.6
MDE WITH SEVERE IMPAIRMENT 14.2 12.8 12.2 11.9
Male 14.7 10.4 13.9 13.0
Female 14.1 13.6 11.6 11.5
NO MDE 4.0a 3.2a 2.9 2.5
Male 4.3a 3.6a 3.0 2.8
Female 3.7a 2.8 2.8 2.2
ILLICIT DRUG USE DISORDER        
MDE 8.0 7.6 8.1 8.0
Male 7.8 7.5 9.5 9.2
Female 8.0 7.7 7.6 7.6
MDE WITH SEVERE IMPAIRMENT 10.3 9.3 9.5 9.4
Male 10.0 8.2 11.4 9.6
Female 10.4 9.7 8.8 9.3
NO MDE 2.8a 2.4a 2.2 1.8
Male 3.1a 2.8 2.4 2.2
Female 2.5a 1.9a 2.0a 1.4
ALCOHOL USE DISORDER        
MDE 6.7a 5.9 5.1 4.6
Male 7.0 3.4 5.5 5.3
Female 6.6a 6.8a 5.0 4.3
MDE WITH SEVERE IMPAIRMENT 8.1a 7.0 5.5 5.5
Male 8.9 4.0 5.9 6.2
Female 7.8 8.0a 5.3 5.2
NO MDE 1.9a 1.3 1.2 1.1
Male 2.1a 1.4 1.1 1.0
Female 1.8 1.3 1.4 1.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2018.
190418
Table 11.12A – Co-Occurring Substance Use Disorder, Illicit Drug Use Disorder, or Alcohol Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, by Gender: Numbers in Thousands, 2015-2018
Substance Use Disorder (SUD), Illicit Drug Use Disorder
(IDUD), or Alcohol Use Disorder (AUD) and MDE/Gender
2015 2016 2017 2018
SUD and MDE 350 333 345 358
Male 87 72a 101 114
Female 263 261 244 244
SUD and MDE with Severe Impairment 303 278 276 288
Male 70 56 81 82
Female 232 222 195 207
IDUD and MDE 241 236 260 279
Male 57 59 80 87
Female 184 177 180 193
IDUD and MDE with Severe Impairment 219 202 215 227
Male 48 44 66 60
Female 172 158 149 167
AUD and MDE 202 182 164 159
Male 51 27 47 50
Female 151 156a 118 108
AUD and MDE with Severe Impairment 172 152 124 132
Male 43 22 34 39
Female 129 130 90 93
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2018.
190418
Table 11.12B – Co-Occurring Substance Use Disorder, Illicit Drug Use Disorder, or Alcohol Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, by Gender: Percentages, 2015-2018
Substance Use Disorder (SUD), Illicit Drug Use Disorder
(IDUD), or Alcohol Use Disorder (AUD) and MDE/Gender
2015 2016 2017 2018
SUD and MDE 1.4 1.4 1.4 1.5
Male 0.7 0.6a 0.8 0.9
Female 2.2 2.2 2.1 2.1
SUD and MDE with Severe Impairment 1.2 1.1 1.1 1.2
Male 0.6 0.5 0.7 0.7
Female 2.0 1.9 1.6 1.8
IDUD and MDE 1.0 1.0 1.1 1.2
Male 0.5 0.5 0.6 0.7
Female 1.6 1.5 1.5 1.6
IDUD and MDE with Severe Impairment 0.9 0.8 0.9 0.9
Male 0.4 0.4 0.5 0.5
Female 1.4 1.3 1.3 1.4
AUD and MDE 0.8 0.8 0.7 0.7
Male 0.4 0.2 0.4 0.4
Female 1.3 1.3 1.0 0.9
AUD and MDE with Severe Impairment 0.7 0.6 0.5 0.5
Male 0.3 0.2 0.3 0.3
Female 1.1 1.1 0.8 0.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2018.
190418
Table 11.13A – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with Major Depressive Episode in Past Year: Numbers in Thousands, 2004-2018
Type of Treatment 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
SAW OR TALKED TO A HEALTH
PROFESSIONAL OR USED
PRESCRIPTION MEDICATION
856a 778a 700a 739a 731a 638a 682a 724a 791a 944a 1,076a 1,139a 1,223 1,286 1,371
Saw or Talked to a Health Professional BUT
   Did Not Use Prescription Medication
425a 404a 407a 372a 406a 358a 370a 397a 431a 522a 543a 596a 571a 625a 749
Used Prescription Medication BUT Did Not
   See or Talk to a Health Professional
76 58 47 53 60 46a 58 52 52 94 75 87 59 76 77
Saw or Talked to a Health Professional
   AND Used Prescription Medication
342a 308a 241a 307a 259a 231a 252a 272a 302a 316a 447 447 576 570 533
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2018.
190418
Table 11.13B – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with Major Depressive Episode in Past Year: Percentages, 2004-2018
Type of Treatment 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
SAW OR TALKED TO A HEALTH
PROFESSIONAL OR USED
PRESCRIPTION MEDICATION
38.7 35.9a 35.9a 37.0 36.3 33.0a 35.8a 36.3 36.0a 36.9 39.6 37.9 40.2 40.3 40.0
Saw or Talked to a Health Professional BUT
   Did Not Use Prescription Medication
19.3 18.6 20.9 18.6 20.2 18.5a 19.4 19.9 19.6 20.4 20.0 19.8 18.8 19.6 21.8
Used Prescription Medication BUT Did Not
   See or Talk to a Health Professional
3.4a 2.7 2.4 2.7 3.0 2.4 3.0 2.6 2.4 3.7 2.8 2.9 1.9 2.4 2.2
Saw or Talked to a Health Professional
   AND Used Prescription Medication
15.5 14.1 12.3a 15.3 12.8 11.9a 13.2 13.6 13.7 12.3a 16.4 14.8 18.9a 17.9 15.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section 3.3.5 in Chapter 3 of the 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2018.
190418
Table 11.14A – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services (Specialty or Nonspecialty) in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) and MDE with Severe Impairment Status: Numbers in Thousands, 2015-2018
Substance Use Disorder (SUD) Status/MDE Status/Receipt of
Substance Use Treatment (SU Tx) and Mental Health (MH) Services
2015 2016 2017 2018
SUD and MDE        
Received SU Tx at a Specialty Facility OR MH Services 221 239 216 234
Received SU Tx at a Specialty Facility BUT NOT MH Services * 5 * 3
Received MH Services BUT NOT SU Tx at a Specialty Facility 208 219 195 211
Received SU Tx at a Specialty Facility AND MH Services 13 15 20 19
Received NEITHER SU Tx at a Specialty Facility NOR MH Services 129 94 128 122
SUD and MDE with Severe Impairment        
Received SU Tx at a Specialty Facility OR MH Services 202 208 181 206
Received SU Tx at a Specialty Facility BUT NOT MH Services * 5 * 3
Received MH Services BUT NOT SU Tx at a Specialty Facility 189 188 160 190
Received SU Tx at a Specialty Facility AND MH Services 13 15 20 13
Received NEITHER SU Tx at a Specialty Facility NOR MH Services 101 70 95 80
SUD and No MDE        
Received SU Tx at a Specialty Facility OR MH Services 277a 249a 227 173
Received SU Tx at a Specialty Facility BUT NOT MH Services 12 23 8 12
Received MH Services BUT NOT SU Tx at a Specialty Facility 245a 205a 198 145
Received SU Tx at a Specialty Facility AND MH Services 20 21 20 15
Received NEITHER SU Tx at a Specialty Facility NOR MH Services 563a 422a 379 338
MDE and No SUD        
Received SU Tx at a Specialty Facility OR MH Services 1,283a 1,440 1,551 1,550
Received SU Tx at a Specialty Facility BUT NOT MH Services 0 0 * *
Received MH Services BUT NOT SU Tx at a Specialty Facility 1,276a 1,439 1,544 1,547
Received SU Tx at a Specialty Facility AND MH Services 7 1 7 3
Received NEITHER SU Tx at a Specialty Facility NOR MH Services 1,389 1,297a 1,288a 1,561
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Specialty facilities for substance use treatment include hospitals (inpatient only), rehabilitation facilities (inpatient or outpatient), or mental health centers.
NOTE: Mental health services for persons aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health service information were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2018.
190418
Table 11.14B – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services (Specialty or Nonspecialty) in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) and MDE with Severe Impairment Status: Percentages, 2015-2018
Substance Use Disorder (SUD) Status/MDE Status/Receipt of
Substance Use Treatment (SU Tx) and Mental Health (MH) Services
2015 2016 2017 2018
SUD and MDE        
Received SU Tx at a Specialty Facility OR MH Services 63.1 71.9 62.7 65.7
Received SU Tx at a Specialty Facility BUT NOT MH Services * 1.5 * 0.8
Received MH Services BUT NOT SU Tx at a Specialty Facility 59.4 65.8 56.8 59.5
Received SU Tx at a Specialty Facility AND MH Services 3.8 4.6 5.9 5.4
Received NEITHER SU Tx at a Specialty Facility NOR MH Services 36.9 28.1 37.3 34.3
SUD and MDE with Severe Impairment        
Received SU Tx at a Specialty Facility OR MH Services 66.7 74.8 65.6 72.1
Received SU Tx at a Specialty Facility BUT NOT MH Services * 1.8 * 1.0
Received MH Services BUT NOT SU Tx at a Specialty Facility 62.4 67.5 58.2 66.4
Received SU Tx at a Specialty Facility AND MH Services 4.3 5.5 7.4 4.7
Received NEITHER SU Tx at a Specialty Facility NOR MH Services 33.3 25.2 34.4 27.9
SUD and No MDE        
Received SU Tx at a Specialty Facility OR MH Services 33.0 37.1 37.4 33.8
Received SU Tx at a Specialty Facility BUT NOT MH Services 1.3 3.5 1.2 2.4
Received MH Services BUT NOT SU Tx at a Specialty Facility 29.2 30.5 32.7 28.4
Received SU Tx at a Specialty Facility AND MH Services 2.4 3.1 3.3 2.8
Received NEITHER SU Tx at a Specialty Facility NOR MH Services 67.0 62.9 62.6 66.2
MDE and No SUD        
Received SU Tx at a Specialty Facility OR MH Services 48.0 52.6 54.6a 49.8
Received SU Tx at a Specialty Facility BUT NOT MH Services 0.0 0.0 * *
Received MH Services BUT NOT SU Tx at a Specialty Facility 47.7 52.6 54.4a 49.7
Received SU Tx at a Specialty Facility AND MH Services 0.3 0.0 0.2 0.1
Received NEITHER SU Tx at a Specialty Facility NOR MH Services 52.0 47.4 45.4a 50.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Specialty facilities for substance use treatment include hospitals (inpatient only), rehabilitation facilities (inpatient or outpatient), or mental health centers.
NOTE: Mental health services for persons aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health service information were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a The difference between this estimate and the 2018 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015-2018.

Go to Top of PageGo to the Table of Contents